-
Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024
03 Jul 2024 21:30 GMT
Navidea Biopharmaceuticals, Inc. (OTC: NAVB) (“Navidea” or the “Company”), a company … Company’s therapeutic assets.
About Navidea
Navidea Biopharmaceuticals, Inc. (OTC: NAVB) is a … http://ir.navidea.com.
Investors are urged to consider statements …
-
Head-To-Head Survey: Navidea Biopharmaceuticals (NYSE:NAVB) versus Cardio Diagnostics (NASDAQ:CDIO)
25 Jan 2024 08:50 GMT
… Great Investing Ideas?
Cardio Diagnostics has lower revenue, but higher earnings than Navidea Biopharmaceuticals … are owned by institutional investors. 43.7% of Navidea Biopharmaceuticals shares are owned by …
-
Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
27 Jan 2024 00:31 GMT
… does not impact Navidea’s business operations.
About Navidea
Navidea Biopharmaceuticals, Inc. (OTC: … investor capital, to craft bespoke capital solutions which include private equity investment … http://ir.navidea.com.
Investors are urged to consider …
-
Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by Analysts at StockNews.com
16 Jan 2024 06:47 GMT
… .
Institutional Investors Weigh In On Navidea Biopharmaceuticals
Want More Great Investing Ideas?
Institutional investors have … institutional investors own 15.75% of the company’s stock.
About Navidea Biopharmaceuticals …
-
Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by StockNews.com
04 Jan 2024 08:00 GMT
… of Navidea Biopharmaceuticals
Want More Great Investing Ideas?
A number of institutional investors and … . Institutional investors own 15.75% of the company’s stock.
Navidea Biopharmaceuticals Company …
-
Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated at StockNews.com
19 Dec 2023 08:58 GMT
… Weigh In On Navidea Biopharmaceuticals
Want More Great Investing Ideas?
Institutional investors have recently … by institutional investors.
About Navidea Biopharmaceuticals
(Get Free Report)
Navidea Biopharmaceuticals, Inc, a biopharmaceutical company, …
-
Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com
25 Nov 2023 10:58 GMT
… Weigh In On Navidea Biopharmaceuticals
Want More Great Investing Ideas?
Institutional investors and hedge … institutional investors and hedge funds.
About Navidea Biopharmaceuticals
(Get Free Report)
Navidea Biopharmaceuticals, Inc, a biopharmaceutical …
-
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
01 Dec 2023 13:50 GMT
… Fix, Fund, Propel approach.”
About Navidea
Navidea Biopharmaceuticals, Inc. (OTC: NAVB) is … investor capital, to craft bespoke capital solutions which include private equity investment … http://ir.navidea.com.
Investors are urged to consider …
-
Navidea Biopharmaceuticals (NYSE:NAVB) Research Coverage Started at StockNews.com
31 Oct 2023 06:58 GMT
… quarter.
Institutional Investors Weigh In On Navidea Biopharmaceuticals
Want More Great Investing Ideas?
Hedge … investors and hedge funds.
Navidea Biopharmaceuticals Company Profile
(Get Free Report)
Navidea Biopharmaceuticals, Inc, a biopharmaceutical …
-
StockNews.com Initiates Coverage on Navidea Biopharmaceuticals (NYSE:NAVB)
06 Oct 2023 18:05 GMT
… Funds Weigh In On Navidea Biopharmaceuticals
Want More Great Investing Ideas?
A number … of hedge funds and other institutional investors … during the last quarter. Institutional investors and hedge funds own 15 …
About
© 1995-2025